Pluri Inc. Receivables, Net, Current
Pluri Inc. (PLUR) had Receivables, Net, Current of $1.28 million as of 2013-03-31, per its 10-Q filed 2013-05-08.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:ReceivablesNetCurrent · last filed 2013-05-08
- 2013-03-31: Receivables, Net, Current $1.28M.
- 2012-12-31: Receivables, Net, Current $1.70K.
- 2012-09-30: Receivables, Net, Current $1.67M.
- 2012-06-30: Receivables, Net, Current $383.00K; Receivables, Net, Current as first filed $135.00K.
| Period end | Receivables, Net, Current | Receivables, Net, Current as first filed |
|---|---|---|
| 2013-03-31 | $1.28M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $1.70K 10-Q · filed 2013-01-31 | |
| 2012-09-30 | $1.67M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $383.00K 10-Q · filed 2013-05-08 | $135.00K 10-K · filed 2012-09-10 |
| 2012-03-31 | $211.00K 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $266.00K 10-Q · filed 2012-02-09 | |
| 2011-09-30 | $225.00K 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $154.00K 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |